Live feed
Filing
SC 13D/A
SC 13D/A0001144204-18-006635·CELGENE CORP /DE/
Schedule 13D ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2018-02-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-006635
- Form type
- SC 13D/A
- Filer
- CELGENE CORP /DE/
- CIK
- CIK 816284
- Filed
- Feb 08, 2018
- Reporting period
- Feb 07, 2018
- Description
- Schedule 13D beneficial ownership